Skip to main content
Top
Published in: Supportive Care in Cancer 1/2013

01-01-2013 | Original Article

Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL)

Authors: Patricia J. Hollen, Richard J. Gralla, John A. Stewart, Jacinta M. Meharchand, Rafal Wierzbicki, Natasha Leighl

Published in: Supportive Care in Cancer | Issue 1/2013

Login to get access

Abstract

Purpose

This trial assessed the ability to enhance health-related quality of life (HRQL) and patient-reported outcome (PRO) evaluation in trials and patient management using computer assistance with a handheld device, called a personal digital assistant. The study assessed ease of use and psychometric properties of this approach, comparing the Lung Cancer Symptom Scale (LCSS) paper form with the electronic (eLCSS-QL). Objectives were to: (1) measure completion times; (2) evaluate acceptability by patients, nurses, and physicians; (3) determine the correlation of the eLCSS-QL with the paper version; and (4) determine the feasibility of using a shorter visual analogue scale (VAS) in the electronic version.

Patients and methods

Patients were entered at 12 COMET clinics. All had: (a) stage III or IV non-small cell lung cancer, (b) Karnofsky performance status (KPS) ≥ 60, (c) no prior chemotherapy, and (d) received initial courses of docetaxel + platinum. Of the148 patients enrolled, characteristics were: men, 57 %; median, KPS 80 %; and median age, 67 years. Of these, 131 patients completed the evaluation form.

Results

The eLCSS-QL had excellent acceptance by patients, nurses, and physicians. Patients required 2.2 min (mean) to complete the eLCSS-QL. Reliability coefficients using Cronbach’s alpha were high for the paper (0.84) and electronic (0.88) versions. The correlation coefficient between forms was high (0.92). The length of the VAS on the handheld pc (53 mm versus 100 mm on the paper format) resulted in nearly identical scores.

Conclusions

The high acceptance rate by patients and professionals, the rapid completion time, ease of use, and strong psychometric properties confirm that the electronic LCSS (eLCSS-QL) is practical for use in trials and patient management. This study indicates that computer assistance helps overcome barriers associated with evaluating HRQL and PROs.
Literature
1.
go back to reference Lipscomb J, Gotay CC, Snyder CF (2007) Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 57:278–300PubMedCrossRef Lipscomb J, Gotay CC, Snyder CF (2007) Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 57:278–300PubMedCrossRef
2.
go back to reference Morris J, Perez D, McNoe B (1998) The use of quality of life data in clinical practice. Qual Life Res 7:85–91PubMedCrossRef Morris J, Perez D, McNoe B (1998) The use of quality of life data in clinical practice. Qual Life Res 7:85–91PubMedCrossRef
3.
go back to reference Higginson IJ, Carr AJ (2001) Using quality of life measures in the clinical setting. B Med J 322:1297–1300CrossRef Higginson IJ, Carr AJ (2001) Using quality of life measures in the clinical setting. B Med J 322:1297–1300CrossRef
4.
go back to reference Passik SD, Kirsh KL (2000) The importance of quality-of-life endpoints in clinical trials to the practicing oncologist. Hematol Oncol Clin North Am 14:877–886PubMedCrossRef Passik SD, Kirsh KL (2000) The importance of quality-of-life endpoints in clinical trials to the practicing oncologist. Hematol Oncol Clin North Am 14:877–886PubMedCrossRef
5.
go back to reference Hollen PJ, Gralla RJ, Kris MG, Potanovich LM (1993) Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 29A:S51–S58PubMedCrossRef Hollen PJ, Gralla RJ, Kris MG, Potanovich LM (1993) Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 29A:S51–S58PubMedCrossRef
6.
go back to reference Hollen PJ, Gralla RJ, Kris MG, Cox C, Belani CP, Grunberg SM, Crawford J, Neidhart JA (1994) Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73:2087–2098PubMedCrossRef Hollen PJ, Gralla RJ, Kris MG, Cox C, Belani CP, Grunberg SM, Crawford J, Neidhart JA (1994) Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73:2087–2098PubMedCrossRef
7.
go back to reference Nunnally JC, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York Nunnally JC, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York
8.
go back to reference Bergman B, Aaronson NK, Ahmedzai S et al (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 30A(5):635–642PubMedCrossRef Bergman B, Aaronson NK, Ahmedzai S et al (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 30A(5):635–642PubMedCrossRef
9.
go back to reference Cella DF, Bonomi AE, Lloyd SR et al (1995) Reliability and validity of the Functional Assessment of Cancer Therapy—Lung (FACT-L) quality of life instrument. Lung Cancer 12:199–220PubMedCrossRef Cella DF, Bonomi AE, Lloyd SR et al (1995) Reliability and validity of the Functional Assessment of Cancer Therapy—Lung (FACT-L) quality of life instrument. Lung Cancer 12:199–220PubMedCrossRef
10.
go back to reference Earle CC, Weeks JC (2005) The science of quality-of-life measurement in lung cancer. In: Lipscomb J, Gotay CC, Synder C (eds) Outcomes assessment in cancer: measures, method, and applications. Cambridge University Press, Cambridge, p 171 Earle CC, Weeks JC (2005) The science of quality-of-life measurement in lung cancer. In: Lipscomb J, Gotay CC, Synder C (eds) Outcomes assessment in cancer: measures, method, and applications. Cambridge University Press, Cambridge, p 171
11.
go back to reference Fossella F, Pereira JR, von Pawel J et al (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21:3016–3024PubMedCrossRef Fossella F, Pereira JR, von Pawel J et al (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21:3016–3024PubMedCrossRef
12.
go back to reference Hollen PJ, Gralla RJ, Kris MG, Cox C (1994) Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 2:213–222PubMedCrossRef Hollen PJ, Gralla RJ, Kris MG, Cox C (1994) Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 2:213–222PubMedCrossRef
13.
go back to reference Hollen PJ, Gralla RJ, Kris MG, Eberly SW, Cox C (1999) Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 7:140–148PubMedCrossRef Hollen PJ, Gralla RJ, Kris MG, Eberly SW, Cox C (1999) Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 7:140–148PubMedCrossRef
14.
go back to reference Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310PubMedCrossRef Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310PubMedCrossRef
15.
go back to reference Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428PubMedCrossRef Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428PubMedCrossRef
16.
go back to reference Lin L (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255–268PubMedCrossRef Lin L (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255–268PubMedCrossRef
17.
go back to reference Hollen PJ, Gralla RJ, Kris MG, McCoy S, Donaldson GW, Moinpour CM (2005) A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale: does format affect patient ratings of symptoms and quality of life? Qual Life Res 14:837–847PubMedCrossRef Hollen PJ, Gralla RJ, Kris MG, McCoy S, Donaldson GW, Moinpour CM (2005) A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale: does format affect patient ratings of symptoms and quality of life? Qual Life Res 14:837–847PubMedCrossRef
18.
go back to reference Kraemer HC, Thiemann S (1987) How many subjects? Statistical power analysis in research. Sage, Newbury Park Kraemer HC, Thiemann S (1987) How many subjects? Statistical power analysis in research. Sage, Newbury Park
19.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
20.
go back to reference Hollen PJ, Gralla RJ, Rittenberg CN (2004) Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer. Support Care Cancer 12:767–773PubMedCrossRef Hollen PJ, Gralla RJ, Rittenberg CN (2004) Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer. Support Care Cancer 12:767–773PubMedCrossRef
21.
go back to reference Hollen PJ, Gralla RJ, Symanowski JT, Liepa AM, Bizette GA (2004) Determining the frequency of quality of life assessment in chemotherapy treatment: using the LCSS-Meso in the randomized pemetrexed + cisplatin trial in 448 patients with mesothelioma as an example. J Clin Oncol 22(14S):8125 Hollen PJ, Gralla RJ, Symanowski JT, Liepa AM, Bizette GA (2004) Determining the frequency of quality of life assessment in chemotherapy treatment: using the LCSS-Meso in the randomized pemetrexed + cisplatin trial in 448 patients with mesothelioma as an example. J Clin Oncol 22(14S):8125
Metadata
Title
Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL)
Authors
Patricia J. Hollen
Richard J. Gralla
John A. Stewart
Jacinta M. Meharchand
Rafal Wierzbicki
Natasha Leighl
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 1/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1507-7

Other articles of this Issue 1/2013

Supportive Care in Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine